Carbonic anhydrase (CA)' (EC 4.2.1.1) is present in mammals as at least three isozymes, CA I, CA II, and CA III, whose structural genes appear to have evolved by gene duplications before the divergence of the land vertebrates, i.e., reptiles, birds, and mammals ( 1) . These isozymes are monomeric, zinc metalloenzymes (nfr 29,000) which catalyze the reversible hydration of CO, (2, 3) : the CA I1 isozymes have the highest turnover numbers, followed in order by the CA I and CA III isozymes (45). Aromatic and heterocyclic sulfonamides (e.g., sulfanilamide, acetazolamide) are known to be specific inhibitors of the CA isozymes; however, the affinities of the different CA isozymes for the sulfonamide inhibitors vary with the particular isozyme and type of sulfonamide (5) (6) (7) . Most sulfonamides are strong inhibitors of the mammalian CA II isozymes and usually have lower affinities for the CA I isozymes, but are only weakly bound to the CA III isozymes (5 in the active sites of human CA I and CA II have revealed two important features: (a) the sulfonamide group (-SO,NH?) is firmly liganded, with little mobility, to the zinc ion replacing the solvent ligand (OH-or HzO) normally present at the fourth ligand site, and (b) the aromatic or heterocyclic ring structures appear to interact with certain residues in the hydrophobic part of the active site cavities (3, 7) . ln studies involving the kinetics of CA-sulfonamide binding, it is often important to be able to accurately determine the dissociation constant (&) of a CA-inhibitor complex. For instance, Kd values for azosulfonamide binding were required for studies on the proteolytic degradation of the CA isozymes (8) . Carbonic anhydrase activities are routinely measured using synthetic esters, often of limited water solubility and stability to hydrolysis. Also, no assay is optimal for all three isozymes as CA I and CA II have maximal activities for ester hydrolysis and CO, hydration, respectively, whereas CA III is a relatively poor catalyst for both reactions (2, 3) . Therefore, employing a gel-filtration procedure (9) (10) (11) (12) . we developed a method to obtain values for carbonic an-hydrase-inhibitor binding. By recording chromatograms at two different wavelengths it was possible to determine dissociation constants without the need to measure the area of a flat trough. This was of particular benefit at low levels of inhibitor binding where very shallow negative areas are obtained which are difficult to estimate. This method has a general application. and it is especially useful for ligands which have absorption bands at wavelengths > 340 nm.
EXPERIMENTAL PROCEDURES
Rcqqnts. Neoprontosil (7-acetamido-2-(4'-sulfamylphenylazo) -1 -hydroxynaphthalene -3,6-disulfonate) was obtained from Winthrop Laboratories, New York, and Sephadex G25 superfine from Pharmacia. All other reagents were from Sigma.
En~~,)~zc~I,llr~~ificafion. Human CA 1, human CA II. and bovine CA II were purified from hemolysates. and bovine CA I was from rumen by column chromatography on sulfonamidebound affinity columns (13) . Human CA III was prepared from skeletal muscle extracts by affinity chromatography ( 13) . eluted with a 0 to 0.2 M KI gradient in 0.005 M Tris-SO4 buffer, pH 8.7. and further purified by chromatography on Sephadex G-75 (14) . Bovine and chicken CA III, which bind only very weakly to the sulfonamide column. were separated from the sulfonamide-bound CA I and CA II isozymes by first passing the muscle extracts through an affinity column ( 13), followed by chromatography on DEAE-cellulose with further purification on Sephadex G-75. Carbonic anhydrase activity was measured by an esterase <assay using p-nitrophenyl acetate ( 15). The purified enzymes gave a single band upon SDS-gel electrophoresis ( 16).
Diffivcmv spwtru. The azosulfonamide difference spectra were determined as described ( 15) free inhibitor was known and the dissociation constant was given by k;/ = If (peak area Er/ peak area EJ. This calculation was facilitated by the use of an inhibitor absorbing in the visible spectrum. However, if the extinction coefficients of all components are known at any two wavelengths, then k;I can be calculated from peak areas obtained from elution profiles of repeat chromatograms with the detector set at the two chosen wavelengths. It was also necessary to determine a difference spectrum to monitor ifthe free ligand changes its absorption spectrum upon binding to enzyme.
RESULTS

AND DISCUSSION
The azosulfonamide difference spectra of human CA III and chicken CA III (Fig. 1) were similar in profile to those reported for human CA 1 and CA II ( 15). The concentra- The concentrations of chicken CA III and human CA III were 9 and IO PM. respectively, and that of Neoprontosil was 50 WM. The negative sign indicates a decrease in absorbance of enzyme-inhibitor complex relative to free inhibitor.
The spectra were recorded at 22°C and the buffer was 25 RIM Tris-HCI. pH 8.0.
tion of chicken CA 111 was 9 PM and that of human CA III was 10 PM, both with 50 /*M Neoprontosil which gave ~3% L'r. The spectra were recorded at 22°C. The negative sign indicates a decrease in absorbance of enzymeinhibitor complex relative to free inhibitor. Both CA III enzymes showed a maximum negative absorbance between 485 and 490 nm, and peaks of positive sign at 400 and 550 nm. The chicken CA III also showed a positive peak at 350 nm. The change in millimolar extinction coefficient for inhibitor complexes at 490 nm for human CA III. chicken CA III, and bovine CA III were 8.8. 6.7, and 10.0 mtK' cm-', respectively. The value for human CA III is between the values for human CA 1 and CA II previously reported ( 15). At wavelengths between 370 and 380 nm there was no change in sulfonamide absorbance following binding to the various enzymes. The zero absorbance change was at 380 nm for bovine CA I and CA II and human CA II, and at 370 nm for the other enzymes. The elution profiles of the enzyme-sulfonamide complexes were recorded at the wavelengths giving zero absorbance difference. The elution profile of human CA I recorded at 370 nm after chromatography in buffer plus 1 /IM azosulfonamide showed a sharp symmetrical peak with retention time of 150 s (Fig. 2) . This peak represented the inhibitor bound to the enzyme. and the trough eluting at 18 min was also equivalent to this, as it represents the inhibitor removed from the equilibrated buffer solution as the enzyme migrated down the column. The column used in this chromatogram was 20 cm long and allowed repeat chromatograms at 25min intervals. This time was nearly halved using a column of 12 cm length. During these analyses. the maximum pressure registered at the pump was 400 psi. For the time that the enzyme was within the chromatographic system (< 150 s), there was no evidence of denaturation as monitored by esterase assay. The columns were durable and were used for at least 50 runs without the generation of artifacts due to gel compressibility. The enzyme was dissolved in the solution and 20 ng in IO ~1 was chromatographed at a flow rate of I ml/min and 22°C. The ordinate represents absorhance at 370 nm.
The inhibitor binding to human CA I at various free inhibitor concentrations was determined and plotted in the form suggested by Klotz (21) (Fig. 3) . That is, Et/I, = &/rzIF + l/n, where II is the number of ligand molecules bound per mole of enzyme. The ordinate was derived from the peak areas for enzyme chromatographed with buffer alone (E,) and from enzyme with inhibitor concentrations of 0.025 to 1 PM to give Ih. At these inhibitor concentrations the proportion of complexed enzyme varied from 20 to 90%. From the slope and intercept & is 0.10 PM and n is 1. Figure 3 shows this method can be applied to a range of inhibitor concentrations. However, inhibitor levels giving >90% EZ gave less reproducible results.
The dissociation constants were determined for the various carbonic anhydrases at two or more different inhibitor concentrations at 22°C (Table I) . No difference was observed in K,/ values. obtained for human CA II when the protein concentration was varied from 0.3 to I .5 mg/ml at constant inhibitor level. This indicates that, over this fivefold concentration range. protein-ligand intera-'ion is not dependent on enzyme level ( 11.12). The tendency for the mammalian CA isozymes to bind sulfonamides in the order CA II > CA 1 > CA III was generally reflected in their respective k; values (Table 1) . The reasons for (a) the similar k;, values for bovine CA I and CA Il. (b) the differences in the k; values between human and bovine CA III, and (c) the relatively low & value for chicken CA III (similar to human CA I) were not evident by examining their respective active site residues (1). Although the amino acid sequences for human and chicken CA III isozymes are still incomplete. no differences have as yet been observed for any of the residues postulated to occur in the active sites of the bovine, human. and chicken CA III isozymes ( 1) . The relatively high affinity of chicken CA III for Neoprontosil was not in agreement with the data of Holmes (20) , who showed (using an esterase assay) that 1 mM acetazolamide was required to completely inhibit this isozyme. The IQ values for human CA 1 and CA II are in general agreement with Iso values for acetazolamide inhibition determined using a CO?-hydratase assay (5) .
This adaptation ofthe gel-filtration method of Hummel and Dryer (9) involves the measurement of only sharp elution peaks at two wavelengths and has, by not requiring measurements of shallow negative areas. provided a procedure for determining dissociation constants that was fast and reliable. and has a general application. It is particularly useful for enzymes such as carbonic anhydrase that "r 
